Australia's most trusted
source of pharma news
Monday, 07 October 2024
Posted 27 September 2024 AM
Chimeric Therapeutics has joined forces with Achieve Clinics, a Los Angeles biotech that connects patients to autologous CAR T-cell therapies they may need in the future.
The collaboration centres around Chimeric's CHM CDH17, the the world's first cadherin 17-directed CAR T-cell therapy currently in Phase 1 clinical trials for advanced gastrointestinal (GI) cancers in the US.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.